Feb 12, 2020 / 12:00AM GMT
Presentation
Feb 12, 2020 / 12:00AM GMT
=====================
Corporate Participants
=====================
* David Mark Lamont
CSL Limited - CFO
* Mark Dehring
CSL Limited - Head of IR
* Paul R. Perreault
CSL Limited - MD, CEO & Executive Director
=====================
Conference Call Participants
=====================
* Andrew Goodsall
MST Marquee - Healthcare analyst
* Chris Cooper
Goldman Sachs Group Inc., Research Division - Research Analyst
* David A. Low
JP Morgan Chase & Co, Research Division - Research Analyst
* David Andrew Stanton
Jefferies LLC, Research Division - Equity Analyst
* David Bailey
Macquarie Research - Research Analyst
* Gretel Janu
Crédit Suisse AG, Research Division - Research Analyst
* John Deakin-Bell
Citigroup Inc, Research Division - Director & Head of Healthcare in Australia and New Zealand
* Lyanne Harrison
BofA Merrill Lynch, Research Division - VP
* Saul
CSL Ltd
(ASX:CSL)
A$
283.99
-2.35 (-0.82%)
Market Cap: 137.51 Bil
Enterprise Value: 153.48 Bil
PE Ratio: 35.09
PB Ratio: 5.29
GF Score: 97/100 Half Year 2020 CSL Ltd Earnings Presentation Transcript
Feb 12, 2020 / 12:00AM GMT
Release Date Price:
A$328.25
(+0.77%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot